The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden

[1]  T. Merriman,et al.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  T. Merriman,et al.  Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis , 2018, Annals of the rheumatic diseases.

[3]  Lucio Della Guardia,et al.  Adipocytes properties and crosstalk with immune system in obesity‐related inflammation , 2018, Journal of cellular physiology.

[4]  George Davey Smith,et al.  Recent Developments in Mendelian Randomization Studies , 2017, Current Epidemiology Reports.

[5]  Yoosoo Chang,et al.  Development of Nephrolithiasis in Asymptomatic Hyperuricemia: A Cohort Study. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  L. Jacobsson,et al.  Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study , 2017, Arthritis Research & Therapy.

[7]  M. Lanaspa,et al.  Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study , 2017, Hypertension.

[8]  Hyon K. Choi,et al.  Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review , 2017, The Journal of Rheumatology.

[9]  N. Dalbeth,et al.  Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution. , 2017, Seminars in arthritis and rheumatism.

[10]  M. Petzold,et al.  Factors associated with initiation and persistence of urate-lowering therapy , 2017, Arthritis Research & Therapy.

[11]  M. Neovius,et al.  Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial , 2016, Annals of the rheumatic diseases.

[12]  L. Jacobsson,et al.  Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective , 2016, RMD Open.

[13]  Tony R. Merriman,et al.  Insight into rheumatological cause and effect through the use of Mendelian randomization , 2016, Nature Reviews Rheumatology.

[14]  L. Jacobsson,et al.  Incidence and prevalence of gout in Western Sweden , 2016, Arthritis Research & Therapy.

[15]  Shuohua Chen,et al.  Ideal Cardiovascular Health Metrics and Incident Hyperuricemia , 2016, Arthritis care & research.

[16]  A. Carlsson,et al.  Gout and its comorbidities in the total population of Stockholm. , 2015, Preventive medicine.

[17]  R. Liu,et al.  Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis , 2015, BioMed research international.

[18]  M. Doherty,et al.  Global epidemiology of gout: prevalence, incidence and risk factors , 2015, Nature Reviews Rheumatology.

[19]  Richard J. Johnson.  Why focus on uric acid? , 2015, Current medical research and opinion.

[20]  E. Krishnan,et al.  Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study , 2015, BMJ Open.

[21]  Markku Peltonen,et al.  The incidence of albuminuria after bariatric surgery and usual care in swedish obese subjects (SOS): a prospective controlled intervention trial , 2014, International Journal of Obesity.

[22]  Fang Liu,et al.  Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies , 2014, BMC Nephrology.

[23]  E. Krishnan.  Interaction of Inflammation, Hyperuricemia, and the Prevalence of Hypertension Among Adults Free of Metabolic Syndrome: NHANES 2009–2010 , 2014, Journal of the American Heart Association.

[24]  T. Vos,et al.  The global burden of gout: estimates from the Global Burden of Disease 2010 study , 2014, Annals of the rheumatic diseases.

[25]  A. Levi,et al.  The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort , 2014, Clinical Rheumatology.

[26]  W. Pan,et al.  Gender-specific risk factors for incident gout: a prospective cohort study , 2012, Clinical Rheumatology.

[27]  Hyon K. Choi,et al.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.

[28]  F. Paccaud,et al.  Elevated Serum Uric Acid Is Associated with High Circulating Inflammatory Cytokines in the Population-Based Colaus Study , 2011, PloS one.

[29]  J. Björk,et al.  Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort , 2011, Scandinavian journal of clinical and laboratory investigation.

[30]  Hyon K. Choi,et al.  Hyperuricemia and incident hypertension: A systematic review and meta‐analysis , 2011, Arthritis care & research.

[31]  K. Rock,et al.  Uric acid promotes an acute inflammatory response to sterile cell death in mice. , 2010, The Journal of clinical investigation.

[32]  Hyon K. Choi,et al.  Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. , 2010, Arthritis and rheumatism.

[33]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[34]  W. Bilker,et al.  Gout epidemiology: results from the UK General Practice Research Database, 1990–1999 , 2005, Annals of the rheumatic diseases.

[35]  W. Willett,et al.  Alcohol intake and risk of incident gout in men: a prospective study , 2004, The Lancet.

[36]  P. Chou,et al.  Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. , 2000, The Journal of rheumatology.

[37]  K. Eriksson,et al.  Long‐term outcome of the Malmö Preventive Project: mortality and cardiovascular morbidity , 2000, Journal of internal medicine.

[38]  R. Glynn,et al.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. , 1987, The American journal of medicine.

[39]  E. Trell.  Community-based preventive medical department for individual risk factor assessment and intervention in an urban population. , 1983, Preventive medicine.

[40]  E. Trell,et al.  Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. , 1982, British journal of addiction.

[41]  E. Trell,et al.  Correlations of Serum Lipids and Lipoproteins with Gamma-Glutamyltransferase and Attitude to Alcohol Consumption , 1982, Annals of clinical biochemistry.

[42]  J. Loeb.  The influence of temperature on the solubility of monosodium urate. , 1972, Arthritis and rheumatism.